More good news - Femara helps prevent the return of breast cancer
14th Dec 2005, 15:18 GMT
In more good news for women suffering from breast cancer a study by the the Swiss drugmaker Novartis has shown that their drug Femara benefits women with hormone-sensitive early breast cancer.
More good news - Femara helps prevent the return of breast cancer related news:
- Novartis drug helps prevent breast cancer recurrence — Pharmaceutical Business Review Online
- Aromatase inhibitor shows promise for breast cancer patients — The Cancer Blog
- New Clinical Data Show Dramatic Benefits of Femara for Women with Breast Cancer Even After Prolonged Period of No Anti-Cancer Treatment — Mammography News from StratCenter.com
- New clinical data shows dramatic benefits of Femara� for women with breast cancer even after prolonged period of no anti-cancer treatment — WebWire - Recent Headlines
- Gene variation affects tamoxifen's benefit for breast cancer — EurekAlert! - Cancer
- 'I just got breast cancer.' — Breast Cancer Chronicles
- Exercise can help with cancer — The Cancer Blog
- Taking Hormonal Therapy Right to Prevent Recurrence — Breast Cancer Chronicles
- New Clinical Data Show Dramatic Benefits of Femara(R) for Women with Breast Cancer Even After Prolonged Period of No Anti-Cancer Treatment — PR Newswire: All Releases
- Radiotherapy boosts survival rate for breast cancer patients: study — The Earth Times Online Newspaper
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info